MarketFoolery

Pfizer is considering selling its consumer healthcare business. Would Advil, Chapstick and Centrum vitamins fetch a price tag of $15 billion?  Industry Focus host Kristine Harjes analyzes the opportunity for Pfizer and its shareholders.  We also discuss her recent trip to Greece and it has her thinking about Square.  Plus, Kristine offers an earnings preview of Johnson & Johnson and advice for travelers to Greece.

Thanks to Slack for supporting The Motley Fool.  Slack: Where work happens. Find out why at slack.com

A disappointing opening weekend for “Blade Runner 2049” sends movie theater stocks down. Jason Moser analyzes the increasingly tough economics for movie theaters.  Plus, we dig into broadcast TV advertising and wonder how much longer big brands will pay up for a shrinking audience.  Dan Boyd reports back from his trip to NY Comic-Con and highlights the big presence of streaming services and the best costume on display.

Norwegian Cruise Line Holdings pops after getting added to the S&P 500 Index.  Abi Malin analyzes what investors interested in cruise stocks should be looking for.  Plus, we discuss the potential sale of SeaWorld Entertainment and what GrubHub means to restaurant owners.

Thanks to Bombfell for supporting The Motley Fool.  Get $25 off your first purchase at http://bombfell.com/fool

We’re back from South Carolina!  David Kretzmann shares highlights from our investing conference and analyzes Citron Research’s shorting of Shopify.

Thanks to Bombfell for supporting The Motley Fool.  Get $25 off your first purchase at http://bombfell.com/fool

Chris Hill sits down with Ben Carter and Malcolm Ethridge, hosts of the “Manage Your Damn Money” podcast to talk about how they met, the #1 financial topic millennials want to hear about, Ben’s early attraction to the topic of money, Malcolm’s upcoming marathon and more.

Thanks to Audible for supporting our podcast.  Get a free audiobook with a free 30-day trial at audible.com/fool.